Free shipping on all orders over $ 500

GRL0617

Cat. No. M9654
GRL0617 Structure
Synonym:

GRL-0617

Size Price Availability Quantity
5mg USD 348  USD348 In stock
10mg USD 646  USD646 In stock
25mg USD 1238  USD1238 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GRL0617 is a potent, selective and competitive noncovalent inhibitor of SARS PLPro, with IC50 of 0.6 μM and Ki of 0.49 μM. GRL0617 inhibits SARS-CoV viral replication in Vero E6 cells with an EC50 of 15 microM, and had no associated cytotoxicity. GRL0617 has a unique mode of inhibition whereby it binds within the S4-S3 subsites of the enzyme and induces a loop closure that shuts down catalysis at the active site.

Chemical Information
Molecular Weight 304.39
Formula C20H20N2O
CAS Number 1093070-16-6
Solubility (25°C) DMSO ≥ 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Rima Chaudhuri, et al. J Mol Biol. Comparison of SARS and NL63 papain-like protease binding sites and binding site dynamics: inhibitor design implications

[2] Kiira Ratia, et al. Proc Natl Acad Sci U S A. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication

Related Deubiquitinase Products
TNG348

TNG348 is a novel, oral, potent and selective ubiquitin-specific protease 1 (USP1) inhibitor for studies related to BRCA1/2 mutations and other homologous recombination defect (HRD)+ cancers.

FT-3171

FT-3171 is a small molecule ubiquitin-specific protease 1 (USP1) inhibitor targeting a novel DNA damage repair (DDR) pathway for studies related to solid tumors.

BAY-728

BAY-728 serves as a negative control for BAY-805, a potent and selective USP21 inhibitor.

BAY-805

BAY-805 is a selective inhibitor of the ubiquitin-specific protease USP21 with high selectivity for deubiquitinating enzyme (DUB) targets, kinases, proteases and other common off-target enzymes.

USP1-IN-6

USP1-IN-6 is a USP1 inhibitor (IC50<50 nM).

  Catalog
Abmole Inhibitor Catalog




Keywords: GRL0617, GRL-0617 supplier, Deubiquitinase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.